Sport and Health Sciences, St. Luke's Campus, University of Exeter, Exeter, Devon, UNITED KINGDOM.
Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, Norfolk, UNITED KINGDOM.
Med Sci Sports Exerc. 2022 Apr 1;54(4):609-621. doi: 10.1249/MSS.0000000000002827.
Montmorency cherry concentrate (MCC) supplementation enhances functional recovery from exercise, potentially due to antioxidant and anti-inflammatory effects. However, to date, supporting empirical evidence for these mechanistic hypotheses is reliant on indirect blood biomarkers. This study is the first to investigate functional recovery from exercise alongside molecular changes within the exercised muscle after MCC supplementation.
Ten participants completed two maximal unilateral eccentric knee extension trials after MCC or placebo (PLA) supplementation for 7 d before and 48 h after exercise. Knee extension maximum voluntary contractions, maximal isokinetic contractions, single leg jumps, and soreness measures were assessed before, immediately, 24 h, and 48 h after exercise. Venous blood and vastus lateralis muscle samples were collected at each time point. Plasma concentrations of interleukin-6, tumor necrosis factor alpha, C-reactive protein, creatine kinase, and phenolic acids were quantified. Intramuscular mRNA expressions of superoxide dismutase 1 (SOD1), SOD3, glutathione peroxidase 1 (GPX1), GPX3, GPX4, GPX7, catalase, and nuclear factor erythroid 2-related factor 2 and relative intramuscular protein expressions of SOD1, catalase, and GPX3 were quantified.
MCC supplementation enhanced the recovery of normalized maximum voluntary contraction 1-s average compared with PLA (postexercise PLA, 59.5% ± 18.0%, vs MCC, 76.5% ± 13.9%; 24 h PLA, 69.8% ± 15.9%, vs MCC, 80.5% ± 15.3%; supplementation effect P = 0.024). MCC supplementation increased plasma hydroxybenzoic, hippuric, and vanillic acid concentrations (supplementation effect P = 0.028, P = 0.002, P = 0.003); SOD3, GPX3, GPX4, GPX7 (supplement effect P < 0.05), and GPX1 (interaction effect P = 0.017) gene expression; and GPX3 protein expression (supplementation effect P = 0.004) versus PLA. There were no significant differences between conditions for other outcome measures.
MCC supplementation conserved isometric muscle strength and upregulated antioxidant gene and protein expression in parallel with increased phenolic acid concentrations.
蒙莫朗西樱桃浓缩物(MCC)补充剂可以增强运动后的功能恢复,这可能是由于其抗氧化和抗炎作用。然而,迄今为止,这些机制假设的支持性实证证据依赖于间接的血液生物标志物。本研究首次调查了 MCC 补充后运动后的肌肉中分子变化与运动后的功能恢复。
10 名参与者在 MCC 或安慰剂(PLA)补充 7 天后,分别进行了两次最大单侧离心膝伸试验,然后在运动后 48 小时内进行了试验。在运动前、运动后即刻、24 小时和 48 小时后评估了膝关节最大自主收缩、最大等速收缩、单腿跳和酸痛测量值。在每个时间点采集静脉血和股外侧肌样本。定量检测血浆白细胞介素-6、肿瘤坏死因子-α、C 反应蛋白、肌酸激酶和酚酸的浓度。定量检测肌肉内超氧化物歧化酶 1(SOD1)、SOD3、谷胱甘肽过氧化物酶 1(GPX1)、GPX3、GPX4、GPX7、过氧化氢酶和核因子红细胞 2 相关因子 2 的 mRNA 表达,以及 SOD1、过氧化氢酶和 GPX3 的相对肌肉内蛋白表达。
与 PLA 相比,MCC 补充剂增强了正常化最大自主收缩 1 秒平均恢复(运动后 PLA,59.5%±18.0%,MCC,76.5%±13.9%;24 小时 PLA,69.8%±15.9%,MCC,80.5%±15.3%;补充效果 P=0.024)。MCC 补充剂增加了血浆羟基苯甲酸、马尿酸和香草酸的浓度(补充效果 P=0.028,P=0.002,P=0.003);SOD3、GPX3、GPX4、GPX7(补充效果 P<0.05)和 GPX1(交互作用效果 P=0.017)基因表达;和 GPX3 蛋白表达(补充效果 P=0.004)与 PLA 相比。在其他结果方面,两种条件之间没有显著差异。
MCC 补充剂与酚酸浓度增加平行,可保持等长肌肉力量,并上调抗氧化基因和蛋白质表达。